Conclusions
toxicity, ovarian cancer, nephrotoxicity
OVARIAN CANCER
ST significantly reduces acute renal toxicity associated with HIPEC with cisplatin in ovarian cancer patients. As nephrotoxicity is high in HIPEC with cisplatin, nephroprotective agents should be considered.